Actuate Therapeutics, Inc. · NASDAQ:ACTU

Actuate Therapeutics, Inc. shareholders

As of Sep 30, 2026, 38 institutions reported holding Actuate Therapeutics, Inc., 22.0% of its shares. Largest: BIOS Capital Management, LP, Voss Capital, LP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Actuate Therapeutics, Inc.ChangeFiled
BIOS Capital Management, LP10M16.6%no changeNov 13, 2026
Voss Capital, LP1.9M3.1%+174KNov 16, 2026
Vanguard453K0.75%no changeNov 13, 2026
Geode Capital104K0.17%−8,239Nov 6, 2026
Texas Capital Bank Wealth Management Services Inc103K0.17%no changeNov 9, 2026
Palogic Value Management, L.P.100K0.17%no changeNov 16, 2026
Millennium90,1950.15%−6,489Nov 16, 2026
ABS Investment Management LLC73,1860.12%no changeNov 16, 2026
BlackRock66,9440.11%−23,091Nov 13, 2026
Rock Creek Group LLC50,0000.08%+10,737Nov 9, 2026

Actuate Therapeutics, Inc. insider trades